PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD
Gordon Freeman, PhD. Professor of Medicine, Harvard Medical School Host: Patrick Hogan A fascinating look at what’s new in cancer immunology research and Dr. Freeman’s findings regarding B7-1 and B7-2 proteins. A closer look at advances in checkpoint inhibitor / blockage approaches. Seminar hosted by La Jolla Institute for Immunology in San Diego, CA. #STEM #STEMCareers #Cancer #Oncology #CancerTherapies #Immunotherapies www.lji.org
▶︎
Antibody responses to SARS-CoV-2 infection and vaccination - Florian Krammer Ph.D.
▶︎
Immune Checkpoint Blockade in Cancer Therapy
▶︎
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers
▶︎
NATURE AND BEYOND: Fc Mediated Enhancement of Anti-Viral Antibodies - Jon Yewdell, M.D., Ph.D.
▶︎
Cancer Immunotherapy 101 with Dr. E. John Wherry
▶︎
CT SCAN RESULTS ARE IN… & It’s Finally Good News! | Cancer Update
▶︎
Arlene Sharpe: Roles of the PD-1 pathway in controlling tolerance & tumor immunity
▶︎
Immuno-oncology: Cold to Hot Tumours
▶︎
Breaking Myths: What Really Fuels Cancer Growth, with Dr. Fung and Dr. Seyfried | TCP Ep. 71
▶︎
The Future of Cancer Immunotherapy with Dr. James Allison
▶︎
Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
▶︎
The Latest in Immunotherapy to Treat Cancer
▶︎
Cancer Immunotherapy Basics: Understand the science behind this cutting-edge treatment
▶︎
Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, Ph.D.
▶︎
PD-L1 Testing by Immunohistochemistry
▶︎
Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li
▶︎
CAR-T Cells: Engineered Cancer Killers
▶︎
The Cancer Immunotherapy Toolbox: How Does the Immune System Work, with Miriam Merad, MD, PhD
▶︎
Functional genomics of T cell metabolism and immuno-oncology - Hongbo Chi, Pd.D.
▶︎